Ophthotech (OPHT) Jumps: Stock Rises 24.5%

Zacks Equity Research

Wed, May 21, 2014, 6:44 AM

Ophthotech Corporation (OPHT) was a big mover last session, as its shares rose nearly 25% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend for the healthcare company, as the stock is now trading above the volatile price range of $30.45 to $35.11 in the past one-month timeframe.

In the last 30 days, the company witnessed four positive estimate revisions and the Zacks Consensus Estimate also moved higher, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if yesterday’s jump can turn into more strength down the road.

Ophthotech currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Better-ranked stocks in the medical sector include TrovaGene, Inc. (TROV), ZIOPHARM Oncology, Inc. (ZIOP) and Agenus Inc. (AGEN). All three sport a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

ZIOPHARM ONCOLOGY INC (ZIOP): Free Stock Analysis Report

TROVAGENE NEW (TROV): Free Stock Analysis Report

OPHTHOTECH CORP (OPHT): Free Stock Analysis Report

AGENUS INC (AGEN): Free Stock Analysis Report

Zacks Investment Research

Mark Zuckerberg got $24.4 million in ‘other compensation’ in 2023—but Meta also treated staff well, with the median employee making $379,000
On paper, Mark Zuckerberg is Meta’s lowest-paid employee, with a $1 dollar salary and no bonus.
Fortune•1d ago
$433 Billion Gone! One Stock Loses More Value Than Tesla
Tesla's loss of $328.3 billion this year in stock value certainly hurts. But it's only the second-largest market value loss in the S&P 500.
Investor's Business Daily•1d ago
Stock market today: US futures tumble after Meta's reality check, soft GDP print
Meta's AI reality check has dented hopes for a Big Tech revival for stocks, with a GDP update waiting in the wings.
Yahoo Finance•36m ago
The Fed's Key Inflation Rate Sizzles As GDP Slows; S&P 500 Futures Slide
The key Federal Reserve inflation rate, the core PCE price index, reared up in Q1 as GDP grew at a slower pace.
Investor's Business Daily•14m ago
The Vanguard 500 Index Fund Is Great, But Another Vanguard ETF Has Outperformed It the Past Decade
This growth ETF has nicely outperformed the S&P 500 since its inception.
Motley Fool•3h ago
Bitcoin Just Did Something It Has Only Done 3 Times Before. The Cryptocurrency Usually Does This Next.
Bitcoin block subsidies were recently reduced by half for the fourth time in history, and halving events have always led to significant price appreciation.
Motley Fool•4h ago
One Member of Congress Is Going Against the Grain and Selling This Skyrocketing Stock-Split Stock
One of Capitol Hill's most-active stock traders is sending a company with well-defined competitive advantages -- that also happens to be on the verge of its first-ever stock split -- to the chopping block.
Motley Fool•4h ago
China's Temu Takes Over 17% Of US Market Share, Cutting Jobs From American Amazon And Decimating Small Businesses
With rising inflation, American consumers are increasingly turning to the Chinese e-commerce platform Temu for their shopping needs. With its enticing tagline “Shop like a billionaire,” Temu has captured 17% of the U.S. market share, posing a challenge to traditional American retailers such as Amazon.com Inc., Dollar Tree Inc. and Five Below Inc. The rise highlights the lucrative and disruptive nature of startups. Owned and operated by PDD Holdings Inc. (NASDAQ:PDD), Temu offers a wide range of
Benzinga•17h ago
Analysts reset Microsoft stock price targets ahead of highly anticipated earnings
Microsoft, which overtook Apple as the world's most valuable company earlier this year, is looking to cement its AI market leadership.
TheStreet•14h ago
Altria tops first quarter sales on higher pricing, robust demand for smokeless alternatives
Like other tobacco giants, Altria has been revamping its portfolio of products to keep up with consumers switching from traditional tobacco products to vapes or other alternatives and as inflation-hit smokers switched to cheaper brands. The company's net revenue came in at $5.58 billion in the first quarter, topping analyst expectations of $4.71 billion, while profit on an adjusted basis came in line with expectations. Last year, Altria launched a lower-priced version of its flagship Marlboro brand and finalized its acquisition of e-cigarette startup NJOY Holdings, expanding its portfolio to include pod-based vapes.
Reuters•1h ago

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Ophthotech (OPHT) Jumps: Stock Rises 24.5%

Recommended Stories

Mark Zuckerberg got $24.4 million in ‘other compensation’ in 2023—but Meta also treated staff well, with the median employee making $379,000

$433 Billion Gone! One Stock Loses More Value Than Tesla

Stock market today: US futures tumble after Meta's reality check, soft GDP print

The Fed's Key Inflation Rate Sizzles As GDP Slows; S&P 500 Futures Slide

The Vanguard 500 Index Fund Is Great, But Another Vanguard ETF Has Outperformed It the Past Decade

Bitcoin Just Did Something It Has Only Done 3 Times Before. The Cryptocurrency Usually Does This Next.

One Member of Congress Is Going Against the Grain and Selling This Skyrocketing Stock-Split Stock

China's Temu Takes Over 17% Of US Market Share, Cutting Jobs From American Amazon And Decimating Small Businesses

Analysts reset Microsoft stock price targets ahead of highly anticipated earnings

Altria tops first quarter sales on higher pricing, robust demand for smokeless alternatives